Accurate Diagnosis of High-Risk Pulmonary Nodules Using a Non-Invasive Epigenetic Biomarker Test
Our epigenetic biomarker panel detected non-small-cell lung cancer early in a high-risk patient group with high sensitivity and accuracy. The epigenetic biomarker model was particularly effective in identifying high-risk lung nodules, including small, part-solid, and non-solid nodules, and provided further evidence for validation.
Authors
- Mariëlle Herzog (ORCID: https://orcid.org/0000-0003-1311-101X)
- Jacob Micallef
- Tzu‐Pin Lu (ORCID: https://orcid.org/0000-0003-3697-0386)
- Pei‐Hsing Chen (ORCID: https://orcid.org/0000-0002-9512-5409)
- Aristotelis Kotronoulas (ORCID: https://orcid.org/0000-0001-9695-0876)
- Jin‐Shing Chen (ORCID: https://orcid.org/0000-0001-5077-4483)
- Hsao‐Hsun Hsu (ORCID: https://orcid.org/0000-0002-0376-1206)
- Dorian Pamart
- Huangling Lu
- Tung-Ming Tsai (ORCID: https://orcid.org/0000-0002-7298-8842)
Institutions
- National Taiwan University (TW)
- National Taiwan University Hospital (TW)
- Volition (Belgium) (BE)
- Volition (United Kingdom) (GB)
Publication Details
- Journal
- Cancers
- Published
- 2025-03-07
- DOI
- https://doi.org/10.3390/cancers17060916
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Ministry of Science and Technology, Taiwan